rs10876528
HOXC4;HOXC5;HOXC6
Waist-Hip Ratio
A
0.700
GeneticVariation
GWASCAT
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
30239722
2019
rs3803042
×
Entrez Id:
3223
Gene Symbol:
HOXC6
HOXC6
Waist-Hip Ratio
A
0.700
GeneticVariation
GWASCAT
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
30239722
2019
rs3803042
×
Entrez Id:
3223
Gene Symbol:
HOXC6
HOXC6
White Blood Cell Count procedure
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs4759316
×
Entrez Id:
3223
Gene Symbol:
HOXC6
HOXC6
Vital capacity
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs12319419
HOXC4;HOXC5;HOXC6
Systolic Pressure
C
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs12319419
HOXC4;HOXC5;HOXC6
Alcohol consumption
C
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs4759319
HOXC4;HOXC5;HOXC6
Alcohol consumption
T
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs4759319
HOXC4;HOXC5;HOXC6
Systolic blood pressure measurement
T
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs4759319
HOXC4;HOXC5;HOXC6
Mean blood pressure
T
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs4759319
HOXC4;HOXC5;HOXC6
Systolic Pressure
T
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs7308105
HOXC4;HOXC5;HOXC6
Alcohol consumption
T
0.700
GeneticVariation
GWASCAT
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries.
29912962
2018
rs10876528
HOXC4;HOXC5;HOXC6
Physical Activity Measurement
A
0.700
GeneticVariation
GWASCAT
Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults.
28448500
2017
rs11614913
HOXC6;MIR196A2
Physical Activity Measurement
T
0.700
GeneticVariation
GWASCAT
Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults.
28448500
2017
rs754133
HOXC4;HOXC5;HOXC6
Physical Activity Measurement
A
0.700
GeneticVariation
GWASCAT
Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults.
28448500
2017
rs754133
HOXC4;HOXC5;HOXC6
Smoking
A
0.700
GeneticVariation
GWASCAT
Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits.
28443625
2017
rs754133
HOXC4;HOXC5;HOXC6
Smoking Behaviors
A
0.700
GeneticVariation
GWASCAT
Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits.
28443625
2017
rs736825
HOXC4;HOXC5;HOXC6
Bone Mineral Density Test
C
0.700
GeneticVariation
GWASDB
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
22504420
2012
rs736825
HOXC4;HOXC5;HOXC6
Bone Density
C
0.700
GeneticVariation
GWASCAT
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
22504420
2012
rs11614913
HOXC6;MIR196A2
Liver carcinoma
0.100
GeneticVariation
BEFREE
We evaluated the associations of <i>miR-499A</i>>G (rs3746444), <i>miR-149C</i>>T (rs2292832), <i>miR-196a2T</i>>C (rs11614913 ), and <i>miR-146aG</i>>C (rs2910164) with HCC susceptibility in 100 HCC patients (70 males and 30 females) and 120 healthy controls (70 males and 50 females), using the PCR-restriction fragment length polymorphism method.
30215231
2019
rs11614913
HOXC6;MIR196A2
Malignant Neoplasms
0.100
GeneticVariation
BEFREE
<b>Conclusions:</b> The present meta-analysis suggests that mir-196a-2 rs11614913 may contribute to the risk of cancer especially in Asians.
30930933
2019
rs11614913
HOXC6;MIR196A2
Primary malignant neoplasm
0.100
GeneticVariation
BEFREE
<b>Conclusions:</b> The present meta-analysis suggests that mir-196a-2 rs11614913 may contribute to the risk of cancer especially in Asians.
30930933
2019
rs11614913
HOXC6;MIR196A2
Liver carcinoma
0.100
GeneticVariation
BEFREE
For miR-196a2 (rs11614913 ) C>T polymorphisms, no significant association was found with HCC risk.
31759375
2019
rs11614913
HOXC6;MIR196A2
Primary malignant neoplasm of lung
0.100
GeneticVariation
BEFREE
These findings suggested that SNPs rs71428439 (miR-149), rs2910164 (miR-146a), rs928508 (mir-30c-1) and rs629367 (let-7a-2) were associated with the lung cancer prevalence, polymorphisms of rs11614913 (miR-196a-2) and rs9280508 (miR-30c-1) significantly influenced the patients' response to platinum-based chemotherapy, which may serve as potential clinical biomarkers to predict lung cancer risk and platinum-based chemotherapy response.
30069329
2018
rs11614913
HOXC6;MIR196A2
Malignant Neoplasms
0.100
GeneticVariation
BEFREE
Maturation of MIR196A2 as a gene regulator with a high potential for targeted cancer therapy can be modulated by the rs11614913 polymorphism.
29802998
2018
rs11614913
HOXC6;MIR196A2
Primary malignant neoplasm
0.100
GeneticVariation
BEFREE
The results showed that miR-196a2 rs11614913 polymorphism is associated with cancer susceptibility, especially in lung cancer (homozygote comparison, OR =0.840, 95% CI =0.734-0.961; recessive model, OR =0.858, 95% CI =0.771-0.955), hepatocellular carcinoma (allelic contrast, OR =0.894, 95% CI =0.800-0.998; homozygote comparison, OR =0.900, 95% CI =0.813-0.997; recessive model, OR =0.800, 95% CI =0.678-0.944), and head and neck cancer (allelic contrast, OR =1.076, 95% CI =1.006-1.152; homozygote comparison, OR =1.214, 95% CI =1.043-1.413).
29535537
2018